Disclosures: Cara Mack: Nothing to Disclose, Yuhuan Luo: Nothing to Disclose, Julia Jezykowski: Nothing to Disclose, Lisa Fraser: Nothing to Disclose, Nitika Gupta: Nothing to Disclose, Alexander Miethke: Mirum Pharmaceutical Inc: Grant/Research Support, Mirum Pharmaceutical Inc: Consultant, Ipsen: Speaking and Teaching, Sarah Taylor: Mirum Pharmaceuticals: Consultant, Ipsen Pharmaceutical: Consultant, Mirum Pharmaceutical: Consultant, Estella Alonso: Nothing to Disclose, Simon Horslen: Nothing to Disclose, Rohit Kohli: Mirum: Consultant, Ipsen: Consultant, Epigen: Grant/Research Support, Sanofi Rare Disease: Consultant, Jean Molleston: Gillead: Grant/Research Support, Albireo: Grant/Research Support, Abbvie: Grant/Research Support, Mirum/Shire: Grant/Research Support, CF FOundation: Grant/Research Support, Binita Kamath: Mirum: Consultant, Mirum: Grant/Research Support, Albireo/Ipsen: Consultant, Albireo/Ipsen: Grant/Research Support, Audentes: Consultant, Stephen Guthery: Nothing to Disclose, Kathleen Loomes: Mirum: Consultant, Albireo/Ipsen: Consultant, Mirum: Clinical trials, Albireo/Ipsen: Clinical trials, John Magee: Nothing to Disclose, Philip Rosenthal: Nothing to Disclose, Pamela Valentino: Grifols: Advisor, Mirum: Speaking and Teaching, Ronald Sokol: Nothing to Disclose 2477 EXTRACELLULAR VESICLE MIRNA ANALYSIS FROM ADOLESCENTS WITH MASLD WITH AND WITHOUT OBSTRUCTIVE SLEEP APNEA/CHRONIC INTERMITTENT HYPOXIA Shikha Sundaram 1 Swati Ghosh 1 Alexander Chaidez 1 Ronald Sokol 2 , 1 Children's Hospital Colorado, 2 University of Colorado School of Medicine Background: Metabolic Associated Steatotic Liver Disease (MASLD) is the predominant cause of chronic liver disease in children
DVY's higher dividend yield and smaller exposure to technology can actually work in the fund's favor during market declines
Its antiinflammatory properties suppress microglial and astrocyte activation, inhibit NFB signaling, and lower proinflammatory cytokines such as IL1 and TNF, thereby alleviating chronic neuroinflammation that exacerbates AD pathology (McGrattan et al
doi: 10.1038/sj.bjp.0707531
Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy
Notwithstanding encouraging existing accomplishments, there are only a few investigations that reveal EXOs to be superior to FDA-authorized nanomedicines (e.g., liposomes)
